Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 08, 2023

BUY
$1.06 - $3.05 $14,993 - $43,142
14,145 New
14,145 $15,000
Q2 2022

Aug 11, 2022

BUY
$1.13 - $2.66 $12,494 - $29,411
11,057 New
11,057 $16,000

Others Institutions Holding BYSI

About BeyondSpring Inc.


  • Ticker BYSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,928,900
  • Market Cap $91.9M
  • Description
  • BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...
More about BYSI
Track This Portfolio

Track Ground Swell Capital, LLC Portfolio

Follow Ground Swell Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ground Swell Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ground Swell Capital, LLC with notifications on news.